The My3D platform passed a milestone as surgeons completed 1,000 patient-specific pelvic reconstructions.
Onkos Surgical announced that surgeons have completed the 1,000th case using its My3D patient-specific pelvic implant platform. The milestone highlights how 3D printing is moving from experimental to routine in complex orthopaedic surgery.
What is My3D
My3D combines advanced imaging, collaborative virtual surgical planning, 3D anatomic modeling, and patient-specific implant design. The platform received FDA 510(k) clearance in 2022 and is built for cases where standard implants do not fit: bone loss from trauma or tumor, revision surgeries, and unusual anatomy.
Surgeons work with Onkos engineers to plan the reconstruction before the operation. The implant is then designed to match the patient's actual bone geometry. That personalized approach reduces the guesswork that comes with trying to adapt an off-the-shelf implant during surgery.
Why the milestone matters
Pelvic reconstruction is a high-stakes procedure. The bone anatomy is irregular, and the margin for error is small. A patient-specific implant lets the surgical team visualize the fit beforehand and adjust the plan without compromising stability.
More than 350 academic medical institutions in the US now use Onkos for complex revision and tumor orthopaedic cases. Reaching 1,000 cases suggests the platform has moved past early adoption and into regular surgical workflow.
Looking ahead
Onkos continues to invest in workflow tools that connect preoperative planning, anatomic modeling, and implant design. The company's broader goal is to expand the personalized approach beyond the pelvis to other complex orthopaedic procedures where standard hardware falls short.
Comments (0)
No comments yet. Be the first!
Leave a Comment